ClinicalTrials.gov Identifier: NCT02840669, First received: July 19, 2016
Locations: Hôpital Pitié-Salpêtrière, Paris, France, Sponsors and Collaborators: Annapurna Therapeutics, Adverum Biotechnologies & Weill Medical College of Cornell University
This study is designed to characterize the cardiac manifestations of FA using cardiac magnetic resonance (CMR), echocardiography, serum cardiac biomarkers and evaluation of fatigue severity, in the context of the neurological disease.
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Subscribe to:
Posts (Atom)
